Zobrazeno 1 - 10
of 26
pro vyhledávání: '"V E, Gruzdev"'
Autor:
R. E. Lakhin, Pavel V. Dunts, N. V. Trembach, A. A. Andreenko, A. Zh. Bayalieva, V. S. Gorokhovsky, E. V. Grigoryev, A. I. Gritsan, V. E. Gruzdev, A. A. Ezhevskaya, V. I. Ershov, I. Z. Kitiashvili, V. N. Kokhno, A. N. Kuzovlev, A. V. Kuligin, A. L. Levit, I. N. Leiderman, M. A. Magomedov, V. V. Myasnikova, A. M. Ovezov, Yu. P. Orlov, K. A. Popugaev, V. I. Potievskaya, I. A. Savvina, S. I. Sitkin, A. P. Spasova, V. V. Fisher, V. E. Khoronenko, N. P. Shen
Publikováno v:
Вестник интенсивной терапии, Iss 2 (2024)
АКТУАЛЬНОСТЬ: Разработка клинических, методических рекомендаций улучшает качество оказания медицинской помощи и снижает риск развити
Externí odkaz:
https://doaj.org/article/696b45b8289b4ce68abfab2308ffb2be
Publikováno v:
Инновационная медицина Кубани, Vol 0, Iss 4, Pp 134-141 (2023)
Adequate postoperative pain management remains a challenge. We discuss pathophysiology of pain after cardiac surgery and describe in detail multimodal and regional anesthesia, their advantages and disadvantages.
Externí odkaz:
https://doaj.org/article/e342ace050644084997dccd37afb845d
Autor:
Yu. E. Ryabukhina, P. A. Zeynalova, A. A. Akhobekov, D. A. Chekini, E. K. Ibragimov, Z. M. Cheishvili, T. I. Kopaliani, V. E. Gruzdev, A. G. Zhukov, T. T. Valiev
Publikováno v:
Онкогематология, Vol 18, Iss 3, Pp 35-43 (2023)
The high efficacy of the currently used combined chemoradiotherapy for Hodgkin’s lymphoma not only significantly increased overall survival, but also made it possible for most patients to achieve the same quality of life as in a healthy population.
Externí odkaz:
https://doaj.org/article/37a60dbe91fb47798cea38fd3fe070c5
Autor:
N. A. Pluzhnikova, V. E. Gruzdev, T. E. Byalik, E. A. Mustafina, T. V. Davydova, P. A. Zeinalova, Z. S. Shikhabova
Publikováno v:
Онкогематология, Vol 15, Iss 1, Pp 51-58 (2020)
Immune thrombocytopenia is an immunosuppressed acquired disease characterized by low platelet levels in peripheral blood and an increased risk of bleeding. This pathology deserves special attention in cases of patients who are scheduled for surgery,
Externí odkaz:
https://doaj.org/article/8fe05c3f14294d4ea67223d9759a68f3
Publikováno v:
Вестник анестезиологии и реаниматологии, Vol 16, Iss 3, Pp 48-54 (2019)
21 clinical cases of abdominal cancer surgery in patients with concomitant myasthenia gravis are combined with the use of the “pharmacological duet” of rocuronium ‒ sugammadex and the mandatory monitoring of neuromuscular conduction. In all cas
Externí odkaz:
https://doaj.org/article/eb4647410d724e96a751caf2a29f8cd4
Publikováno v:
MD-Onco. 3:20-26
Endoscopic trachea stenting is a pressing issue in modern endoscopy. This method is applied in various diseases including benign stenoses associated with complications after long-term mechanical ventilation, malignant stenoses (oncological diseases o
Autor:
Yu. E. Ryabukhina, P. A. Zeynalova, O. L. Timofeeva, F. M. Abbasbeyli, V. E. Gruzdev, A. O. Akhov, A. G. Zhukov, T. T. Valiev
Publikováno v:
MD-Onco. 3:27-34
Chronic pain syndrome developing in patients with oncological diseases significantly decreases their quality of life which makes effective integrative analgetic therapy a pressing issue. Currently, drugs of various pharmaceutical groups are used for
Publikováno v:
MD-Onco. 3:38-47
Severe chronic pain syndrome with high requirement for opioids is frequently complicated by opioid tolerance, hyperalgesia, and other side effects. Special complications occur during anesthesia for high-injury surgical interventions and in the postop
Publikováno v:
Вестник анестезиологии и реаниматологии, Vol 15, Iss 1, Pp 27-31 (2018)
The current development of oncological surgery requires maximum possible radical interventions both for the patients with concurrent conditions and those with large tumors. In thoracic surgery, provision of the adequate surgical access by the anesthe
Externí odkaz:
https://doaj.org/article/92a6438749fa479696d212e0c5d6091f
Autor:
Yu. E. Ryabukhina, O. L. Timofeeva, P. A. Zeynalova, F. M. Abbasbeyli, M. V. Antonets, V. E. Gruzdev, M. A. Anisimov, A. A. Akhobekov, N. A. Kupryshina
Publikováno v:
MD-Onco. 2:47-54
Plasma cell leukemia (PCL) is a rare malignant plasma cell neoplasm with aggressive clinical progression, minimal response to therapy and unfavorable prognosis. Concomitant new coronavirus infection COVID-19 and its complications significantly worsen